Pages that link to "Q24643802"
Jump to navigation
Jump to search
The following pages link to Analysis of RAS oncogene mutations in human lymphoid malignancies (Q24643802):
Displaying 50 items.
- Frequent somatic hypermutation of the 5' noncoding region of the BCL6 gene in B-cell lymphoma (Q24561494) (← links)
- Expression of sprouty2 inhibits B-cell proliferation and is epigenetically silenced in mouse and human B-cell lymphomas (Q24657474) (← links)
- Guanosine triphosphatase stimulation of oncogenic Ras mutants (Q27618496) (← links)
- The effect of the insecticide heptachlor on ras proto-oncogene expression in human myeloblastic leukemia (ML-1) cells (Q28325330) (← links)
- Solution-based scanning for single-base alterations using a double-stranded DNA binding dye and fluorescence-melting profiles (Q28350687) (← links)
- Anti-tumor effect of bisphosphonate (YM529) on non-small cell lung cancer cell lines (Q33269187) (← links)
- RAS inhibitors in hematologic cancers: biologic considerations and clinical applications (Q33819356) (← links)
- Synergistic effect of Bcl2, Myc and Ccnd1 transforms mouse primary B cells into malignant cells (Q33909737) (← links)
- Insights into the biologic and molecular abnormalities in adult acute lymphocytic leukemia (Q34123842) (← links)
- Oncogene activation in human benign tumors of the skin (keratoacanthomas): is HRAS involved in differentiation as well as proliferation? (Q34298327) (← links)
- Quantitation of mRNA by the polymerase chain reaction (Q34324828) (← links)
- Endogenous oncogenic Nras mutation initiates hematopoietic malignancies in a dose- and cell type-dependent manner (Q35112241) (← links)
- Etiology and pathogenesis of AIDS-related non-Hodgkin's lymphoma (Q35174152) (← links)
- Therapeutic efficacy of prenylation inhibitors in the treatment of myeloid leukemia (Q35186888) (← links)
- Higher grade transformation of follicular lymphoma: phenotypic tumor progression associated with diverse genetic lesions (Q35213325) (← links)
- Molecular characterization of primary mediastinal B cell lymphoma (Q35773944) (← links)
- Western thymomas lack Epstein-Barr virus by Southern blotting analysis and by polymerase chain reaction (Q35811735) (← links)
- K-ras activation occurs frequently in mucinous adenocarcinomas and rarely in other common epithelial tumors of the human ovary (Q35831077) (← links)
- Neoplasia of the ampulla of Vater. Ki-ras and p53 mutations (Q35832722) (← links)
- Analysis of alterations of oncogenes and tumor suppressor genes in chronic lymphocytic leukemia. (Q35834161) (← links)
- Cytogenetic and molecular predictors of response in patients with myeloid malignancies without del[5q] treated with lenalidomide. (Q35881223) (← links)
- The proliferation of multiple myeloma colonies (MY-CFUc) in vitro is independent of prognosis and is not associated with mutated N- or K-ras alleles in human bone marrow aspirates (Q36080374) (← links)
- Targeting oncogenic Ras signaling in hematologic malignancies (Q36352506) (← links)
- Ras oncogene mutation in multiple myeloma (Q36356976) (← links)
- Farnesyl transferase inhibitors induce extended remissions in transgenic mice with mature B cell lymphomas (Q36693797) (← links)
- Detection of mutant Ha-ras genes in chemically initiated mouse skin epidermis before the development of benign tumors (Q37108465) (← links)
- Mutational landscape, clonal evolution patterns, and role of RAS mutations in relapsed acute lymphoblastic leukemia (Q37322911) (← links)
- Oncogene-directed alterations in cancer cell metabolism (Q37395416) (← links)
- p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia (Q37535238) (← links)
- Molecular diagnosis of p53 mutations in gastric carcinoma by touch preparation (Q38362385) (← links)
- Tumor markers in human biopsy material (Q38729642) (← links)
- Dinaciclib Induces Anaphase Catastrophe in Lung Cancer Cells via Inhibition of Cyclin-Dependent Kinases 1 and 2. (Q38734002) (← links)
- Aberrant expression of RasGRP1 cooperates with gain-of-function NOTCH1 mutations in T-cell leukemogenesis (Q39437389) (← links)
- Point mutation in codon 61 of N-RAS genes in human myeloma cell lines (Q40538774) (← links)
- N- and K-ras oncogenes in plasma cell dyscrasias. (Q40594604) (← links)
- Alternative effects of RAS and RAF oncogenes on the proliferation and apoptosis of factor-dependent FDC-P1 cells (Q40906374) (← links)
- Functional aspects of apoptosis in hematopoiesis and consequences of failure (Q40913568) (← links)
- Alterations of the p53, p21, p16, p15 and RAS genes in childhood T-cell acute lymphoblastic leukemia (Q40968306) (← links)
- Etiology and pathogenesis of AIDS-related non--Hodgkin's lymphoma (Q41175529) (← links)
- Laboratory probing of oncogenes from human liquid and solid specimens as markers of exposure to toxicants (Q41188296) (← links)
- Cytogenetics and molecular genetics in multiple myeloma (Q41396602) (← links)
- Analysis of methylation in the c-MYC gene in five human myeloma cell lines (Q41696394) (← links)
- Lack of association between N-ras gene mutations and clinical prognosis in Brazilian children with acute lymphoblastic leukemia (Q43792826) (← links)
- c-N-ras is activated infrequently in canine malignant lymphoma (Q44996789) (← links)
- Farnesyltransferase inhibitor BMS-214662 induces apoptosis in B-cell chronic lymphocytic leukemia cells. (Q45051064) (← links)
- RAS pathway mutations as a predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemia (Q47875530) (← links)
- Molecular characterization of disseminated pilocytic astrocytomas. (Q48124187) (← links)
- Comparative analysis of ras proto-oncogene mutations in selected mammalian tumors (Q50759089) (← links)
- Deubiquitinase USP18 Loss Mislocalizes and Destabilizes KRAS in Lung Cancer (Q51119632) (← links)
- RAS oncogene mutations and outcome of therapy for childhood acute lymphoblastic leukemia. (Q52002743) (← links)